J Bernard – författare
Visar alla böcker från författaren J Bernard. Handla med fri frakt och snabb leverans.
8 produkter
8 produkter
Inbunden, Franska, 2022
468 kr
Skickas inom 5-8 vardagar
Häftad, Franska, 2022
357 kr
Skickas inom 5-8 vardagar
Häftad, Engelska, 2010
194 kr
Skickas inom 5-8 vardagar
Inbunden, Engelska, 2010
461 kr
Skickas inom 5-8 vardagar
Häftad, Engelska
536 kr
Skickas inom 3-6 vardagar
Häftad, Franska, 2013
153 kr
Skickas inom 5-8 vardagar
Engelska, 2014
644 kr
Skickas inom 5-8 vardagar
Del 20 - Recent Results in Cancer Research
Rubidomycin
A New Agent against Cancer
Häftad, Engelska, 2013
556 kr
Skickas inom 10-15 vardagar
Trials in the treatment of the leukemias are sometimes based on a hypothesis, as in the case of exchange transfusion [33] or the use of antimetabolites [86]. Or they are conducted empirically as the results of chance observations, as in the case of the use of the nitrogen mustards, urethane, and the Vinca alkaloids. Or they lie between the two, aiming at making use of well established biological facts: examples are the use of ACTH, cortisone and, more recently, the antibiotics. What is true for bacteria may also perhaps be true, if not for elephants, at least for the malignant cells of mammals. It was this idea that lay behind the first attempts at treating cancer and leukemia with antibiotics. The results obtained by the use of certain substances extracted from micro-organisms (actinomycin, azaserine, mito mycin, rufocromomycin), although encouraging at times, were inconsistent. The action of rubidomycin appears to cover a wider spectrum and to be more consistent and more effective. As in the case of Homer and Christopher Columbus, the honor of having given birth to rubidomycin is claimed by more than one country and town. In fact, the same product was discovered in the same year, though quite independently, by a group of French workers [184] who described it under the name of rubidomycin, and by a group of Italian workers [87] who studied it under the name of daunomycin.